Binnopharm Group reported for 6 months of 2024 by IFRS

Binnopharm Group, part of Sistema, IFRS loss for 6 months of 2024 amounted to ₽974.18 million against a profit of ₽583.24 million in the previous year. Revenue rose 9.8% to ₽15.28 billion against ₽13.91 billion a year earlier.